SHORT_NAME	LONG_NAME	ABSTRACT	CANCER_SITE	PATIENT_ID_NAME	INTEGRATED	OVERALL_ACCESS	SCHEMA_NAME	USE_IN_GUI	CONTENT_TYPES	SHOW_CONTENT_IN_GUI
CRC_K_FORD_2007_01	Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC	Patients with metastatic colorectal cancer were enrolled for treatment with cetuximab monotherapy. Transcriptional profiling was conducted on RNA from pre-treatment metastatic site biopsies to identify genes whose expression correlates with best clinical responses. <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE5851">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE5851</a>  <a href="http://www.ncbi.nlm.nih.gov/pubmed/17664471">http://www.ncbi.nlm.nih.gov/pubmed/17664471</a>	COLON CANCER	Sample id	1	PUBLIC	CRC_K_FORD_2007_01	1	CLINIC, MICROARRAY	1, 1